RISK STRATIFICATION AND PATIENT COUNSELING FOR NATALIZUMAB IN MULTIPLE SCLEROSIS

被引：38
作者：
Fox, Robert J. [1 ]
Rudick, Richard A.
机构：
[1] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Dept Neurol, Cleveland, OH 44106 USA
来源：
NEUROLOGY | 2012年 / 78卷 / 06期
基金：
美国国家卫生研究院;
关键词：
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
D O I：
10.1212/WNL.0b013e318245d2d0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：436 / 437
页数：2
相关论文
共 50 条
  • [41] The role of natalizumab in the treatment of multiple sclerosis: benefits and risks
    Singer, Barry A.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (09) : 327 - 336
  • [42] JCV detection in multiple sclerosis patients treated with natalizumab
    Sadiq, Saud A.
    Puccio, Lauren M.
    Brydon, Edward W. A.
    JOURNAL OF NEUROLOGY, 2010, 257 (06) : 954 - 958
  • [43] Natalizumab in Multiple Sclerosis: Long-Term Management
    Clerico, Marinella
    Artusi, Carlo Alberto
    Di Liberto, Alessandra
    Rolla, Simona
    Bardina, Valentina
    Barbero, Pierangelo
    De Mercanti, Stefania Federica
    Durelli, Luca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
  • [44] Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis
    Kornek, Barbara
    Aboul-Enein, Fahmy
    Rostasy, Kevin
    Milos, Ruxandra-Iulia
    Steiner, Irene
    Penzien, Johann
    Hellwig, Kerstin
    Pitarokoili, Kalliopi
    van's Gravesande, Karin Storm
    Karenfort, Michael
    Blaschek, Astrid
    Meyer, Andreas
    Seidl, Rainer
    Debelic, Diana
    Vass, Karl
    Prayer, Daniela
    Kristoferitsch, Wolfgang
    Bayas, Antonios
    JAMA NEUROLOGY, 2013, 70 (04) : 469 - 475
  • [45] Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients
    Heesen, Christoph
    Kleiter, Ingo
    Meuth, Sven G.
    Kraemer, Julia
    Kasper, Juergen
    Koepke, Sascha
    Gaissmaier, Wolfgang
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 376 : 181 - 190
  • [46] Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update
    O'Connor, Paul W.
    Kremenchutzky, Marcelo
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2015, 42 (06) : 372 - 380
  • [47] LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL
    Rigau, Valerie
    Mania, Alexandre
    Befort, Patrice
    Carlander, Bertrand
    Jonquet, Olivier
    Lassmann, Hans
    Camu, William
    Thouvenot, Eric
    NEUROLOGY, 2012, 79 (22) : 2214 - 2216
  • [48] JCV detection in multiple sclerosis patients treated with natalizumab
    Saud A. Sadiq
    Lauren M. Puccio
    Edward W. A. Brydon
    Journal of Neurology, 2010, 257 : 954 - 958
  • [49] Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
    Stueve, Olaf
    Cutter, Gary R.
    JAMA NEUROLOGY, 2014, 71 (08) : 945 - 946
  • [50] Melanoma complicating treatment with Natalizumab (Tysabri) for multiple sclerosis
    Azza Ismail
    Julie Kemp
    Basil Sharrack
    Journal of Neurology, 2009, 256 : 1771 - 1772
12345